Pharma-Biotech Capital Construction Investment Snapshot: $15 Billion in 2014 Project Kick-Offs, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwired) -- 01/15/15 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- With the new year off to an uncertain economic start, it is somewhat heartening to take a look back at some of the high points in 2014. A recent analysis of reported projects that began in 2014, according to Industrial Info''s , revealed that the kicked off a healthy $15 billion worth of construction activity in North America.
Within this article: Details on the industry''s North American growth in 2015, including major projects from Eli Lilly (NYSE:LLY), Michigan State University and Fresenius Medical Care North America.
For details, , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info''s quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what''s happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
William Ploch
713-783-5147
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.01.2015 - 05:00 Uhr
Sprache: Deutsch
News-ID 1330318
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SUGAR LAND, TX
Phone:
Kategorie:
Health & Nutrition
Anmerkungen:
Diese Pressemitteilung wurde bisher 274 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharma-Biotech Capital Construction Investment Snapshot: $15 Billion in 2014 Project Kick-Offs, an Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
